查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034911

全球非體外迴圈冠狀動脈繞道手術手術器械市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Off-Pump Coronary Artery Bypass Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Positioner devices, and Stabilizer Devices
出版日期: | 出版商: iData Research Inc. | 英文 87 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球非體外迴圈冠狀動脈繞道手術手術器械市場報告（至2032年）

2025 年，全球非體外迴圈冠狀動脈繞道手術手術 (OPCAB) 手術器械市場規模為 2.19 億美元。預計未來將以 -1.2% 的複合年成長率萎縮，到 2032 年將達到 2 億美元。

本報告涵蓋了全球 OPCAB 設備市場，包括在搏動性冠狀動脈冠狀動脈繞道術期間使用的穩定器和定位器設備。

分析內容包括銷售量、平均售價（ASP）、手術數量、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

儘管市場規模預計會縮小，但複雜病例中專用器械的使用以及價格上漲預計將部分抵消手術數量的下降。臨床獲益、成本節約以及對特定患者的適用性繼續支撐著市場需求，但手術的複雜性以及外科醫生對心率體外循環冠狀動脈繞道手術移植術（ONCAB）的偏好限制了該技術的廣泛應用。

市場概覽

全球 OPCAB 器械市場包括用於冠狀動脈繞道手術術（無需使用心肺體外迴圈裝置）的器械。

冠狀動脈繞道手術（OPCAB）是在心臟跳動的情況下進行的。由於手術視野會移動，因此需要使用專門的固定和定位裝置，以便外科醫生能夠準確地找到目標血管並進行吻合。

市場區隔將產品分為穩定器器和定位器。穩定器有助於減少手術部位的移動，而定位器則有助於在手術過程中操作和暴露心臟。

總體而言，手術數量預計仍將保持較低水平，因為許多心臟外科醫生仍然傾向於選擇心肺體外迴圈冠狀動脈繞道手術手術（ONCAB）。然而，對於某些患者群體和複雜病例，避免心肺體外迴圈可能帶來顯著優勢，因此非體外循環冠狀動脈繞道手術（OPCAB）仍然是具有臨床意義的選擇。

市場促進因素

非體外循環冠狀動脈繞道手術的臨床益處

接受 OPCAB 手術的患者可能會出現出血率降低、併發症障礙減少和住院時間縮短的情況。

這些優勢主要源自於未使用心肺體外迴圈幫浦。避免使用體外循環可以降低冠狀動脈繞道手術（ONCAB）中血液與人工表面接觸所帶來的一些風險。

這些臨床益處有助於延緩從 OPCAB 過渡到其他治療方案，並支持在能夠從跳動心臟手術中受益的患者中繼續使用該設備。

儘管預計整體市場將會萎縮，但這些優勢可能會在特定的心臟外科手術計畫中維持對穩定器和定位器一定程度的需求。

降低成本

OPCAB 手術比 ONCAB 手術費用低，因為它不需要心肺體外迴圈使用的昂貴設備。

此外，患者在接受 OPCAB 手術後往往恢復得更快，這可以減少因延長住院時間和額外的術後管理而產生的醫院費用。

重視成本控制的醫院可能會繼續在適當的情況下優先考慮 OPCAB，尤其是在臨床結果相當且患者的解剖結構適合這種方法的情況下。

這種成本優勢促使人們繼續使用 OPCAB 設備，即使在手術數量整體成長受到抑制的情況下也是如此。

在複雜案件中使用專用設備

儘管手術數量正在減少，但價格波動預計將部分抵消市場壓力。

對於某些風險等級的患者，基於解剖結構的適宜性和長期療效，非體外循環冠狀動脈旁路移植術（OPCAB）可能仍然是與微創手術相當的選擇。因此，在某些情況下，醫生可能會繼續選擇OPCAB。

在需要精確暴露和固定的複雜手術中，專用穩定器和定位器尤其重要。

即使手術數量整體下降，這些情況下高價設備的使用也預計仍將支撐市場價值。

市場限制

手術固有的困難

OPCAB手術比ONCAB手術難度高很多。

在非體外循環冠狀動脈繞道手術（OPCAB）中，患者的心臟持續跳動，而外科醫師則在內徑僅約1毫米的目標血管上進行精細的吻合術。這一動作帶來了巨大的技術挑戰。

此外，外科醫師通常需要對主動脈進行部分阻斷，以便手工縫合移植物吻合口的近端。因此，即使是接受非體外循環冠狀動脈繞道手術（OPCAB）的患者，也可能面臨一些與主動脈阻斷相關的不利事件。

雖然吻合支架可以幫助解決這個問題，但它們在 OPCAB 手術中的應用率仍然相對較低。

外科醫生傾向於選擇ONCAB

許多醫生在進行冠狀動脈繞道手術手術（CABG）時仍傾向於選擇 ONCAB。

轉為非體外循環冠狀動脈繞道手術（OPCAB）需要額外的培訓，並且對技術要求更高，這可能會讓外科醫生猶豫不決。對於那些職業生涯大部分時間都從事體外循環冠狀動脈繞道手術（ONCAB）的外科醫生來說，尤其如此。

由於 ONCAB 提供了一個無運動、無出血的手術視野，許多外科醫生發現它在移植物的放置和縫合方面更具可預測性。

人們仍然偏好 ONCAB，這限制了 OPCAB 的普及，預計在預測期內將阻礙其進一步成長。

手術需求下降和放緩

對 OPCAB 裝置的需求與手術數量密切相關。

隨著心臟手術模式的改變和替代治療方法的不斷湧現，對非體外循環冠狀動脈繞道手術（OPCAB）的整體需求仍面臨挑戰。因此，市場受到手術數量減少和從體外循環冠狀動脈旁路移植術（ONCAB）過渡到非體外循環冠狀動脈旁路移植術（OPCAB）的病例有限這兩個因素的限制。

即使 OPCAB 具有臨床價值，其應用也很大程度取決於外科醫生的培訓、信心和醫療機構的實踐模式。

因此，儘管在某些情況下會使用專用設備並增加成本，但預計市場規模仍會略有縮小。

市場覆蓋範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量、平均售價。
  • 定性範圍：市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
  • 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
  • 建立市場模型：利用銷售量和平均售價 (ASP) 分析收入，並輔以手術量、競爭市場佔有率分析、設備利用率假設和趨勢。
  • 目標設備：本報告重點在於非體外迴圈冠狀動脈繞道手術手術中使用的設備，分為穩定器設備和定位器設備。

目標市場及區隔

非體外迴圈冠狀動脈繞道手術手術器械市場

  • 設備類型：穩定器器和定位器。

在非搏動性冠狀動脈冠狀動脈繞道手術手術（OPCAB）中，使用穩定器器來抑制冠狀動脈目標部位的移動。這些裝置對OPCAB手術至關重要，因為它們有助於在心臟持續跳動的情況下確保更穩定的手術視野。

定位裝置用於抬升、旋轉和暴露心臟，以便外科醫生能夠接觸到目標血管。這些產品可以提高手術過程中的視野，並改善複雜移植手術的操作空間。

透過合併使用穩定器和定位器，外科醫生無需將患者連接到心肺體外迴圈即可進行冠狀動脈旁路移植術 (CABG)。因此，這些設備已成為非體外循環冠狀動脈繞道手術 (OPCAB) 市場的核心器械類別。

由於 OPCAB 手術技術先進，產品性能、易用性、可靠性和外科醫生的熟練程度都是重要的競爭因素。

本報告分析了市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價。

競爭分析

美敦力是全球冠狀動脈繞道手術（OPCAB）市場的主要競爭對手。

關於穩定器，美敦力公司提供 Octopus™ Evolution、Octopus™ 4 和 Octopus™ 4.3 組織穩定器。這些產品用於在搏動性心血管手術中穩定手術視野。

該公司的心臟定位器產品線包括「Starfish™ Evo」、「Starfish™ 2」、「Urchin™」和「Urchin™ 2」。這些設備完善了美敦力在冠狀動脈繞道手術（OPCAB）固定和定位領域的產品陣容。

隨著美敦力退出心室輔助裝置市場，該公司預計將擴大其在非體外循環冠狀動脈繞道手術（OPCAB）領域的市場佔有率。其成熟的心臟外科產品系列和廣泛的全球佈局鞏固了其在該市場的領先地位。

Getinge是全球OPCAB市場第二大競爭對手。

該公司提供脈動式心臟穩定器和定位器，作為其廣泛的產品系列的一部分。 Getinge 的業務涉及多個領域，並且正在將其投資轉向其他領域。

由於冠狀動脈繞道手術（OPCAB）市場萎縮，預計未來幾年Getinge的市佔率將會下降。然而，其現有的產品基礎以及與醫院建立的穩固關係將支撐其繼續保持市場地位。

Termo 已在整個 OPCAB 市場中佔據第三大地位。

該公司推出的「通用穩定臂™」引入了可連接到胸骨鏡上用於心臟手術的鉸接臂的概念。

憑藉其獨特創新的產品系列，Termo 預計在預測期內進一步鞏固其在 OPCAB 市場的地位，尤其是在客戶需要可靠的穩定解決方案來應對某些搏動性心血管手術的情況下。

科技和醫療治療的發展趨勢

搏動性心血管手術

OPCAB手術旨在避免使用心肺體外迴圈。

對於某些可能受益於避免體外循環的患者而言，這種方法仍然很重要。

穩定技術

固定裝置對於 OPCAB 手術的成功至關重要。

改進的穩定技術使外科醫生能夠在跳動的心臟上進行更精確的搭橋手術。

心臟固定系統

在搏動性心血管手術中，定位器有助於進入冠狀動脈。

這些設備提高了視野清晰度，使外科醫生能夠在各種目標區域進行手術。

注重成本效益的心臟手術

OPCAB 可以省去心肺體外迴圈裝置的使用，從而降低某些手術費用。

這使得醫院持續專注於為合適的患者尋求低成本的手術方法。

選擇性地應用於患者

OPCAB（光學認知輔助冠狀動脈繞道手術）擴大用於特定患者群體，而不是像冠狀動脈繞道手術移植術 (CABG) 那樣廣泛採用。

解剖結構相容性、外科醫師偏好和病患風險因素會影響是否選擇 OPCAB。

透過專用設備提供價格支持

雖然手術數量預計會減少，但高價的專用設備可能會支撐市場價值。

複雜的 OPCAB 手術可能需要先進的穩定器和定位器，這在一定程度上有助於抵消手術數量減少的壓力。

地區

本報告涵蓋全球調查區域，包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

這份報告的意義

  • 目前全球 OPCAB 設備市場規模有多大？預計到 2032 年將發生多大變化？
  • 在預測期內，穩定器和定位器市場將如何發展？
  • 為什麼預計整個 OPCAB 設備市場將會萎縮？
  • 設備價格上漲和專用產品的使用如何抵消減少手術數量的壓力？
  • 哪些患者群體和手術類型仍然支持使用非體外循環冠狀動脈旁路移植術（OPCAB）？
  • 從臨床效益和成本的角度來看，OPCAB 手術與 ONCAB 手術相比如何？
  • 為什麼手術難度高、訓練要求高限制了其廣泛應用？
  • 外科醫師對冠狀動脈繞道手術（ONCAB）的偏好如何影響非體外循環冠狀動脈繞道手術（OPCAB）器械的前景？
  • 全球 OPCAB 設備市場的主要企業有哪些公司？
  • Medtronic、Getinge 和 Termo 在穩定器、定位器和心臟不停跳手術平台這三個類別中分別屬於哪一類？

iData Research 的《全球非體外迴圈冠狀動脈繞道手術術器械市場報告》透過手術模型分析、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、比較競爭對手、了解 OPCAB 手術的趨勢，並協助您制定全球 OPCAB 器材市場的產業計畫。

目錄

調查方法

  • 第一步：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

非體外迴圈冠狀動脈繞道手術手術器械市場

  • 執行摘要
    • 全球非體外迴圈冠狀動脈繞道手術手術器械市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
    • 冠狀動脈繞道手術手術
    • 非體外迴圈冠狀動脈繞道手術繞道手術（CABG）
  • 市場概覽
    • 按細分市場
    • 按地區
  • 市場分析與預測
    • 非體外迴圈冠狀動脈繞道手術手術器械的整體市場
    • 穩定器市場
    • 定位器市場
  • 促進因素和抑制因素
  • 競爭性市佔率分析

附錄

Product Code: iDATA_GLCS26_OFCAB_MC

Global Off-Pump Coronary Artery Bypass Device Market Report to 2032

The global off-pump coronary artery bypass (OPCAB) device market was valued at $219 million in 2025. It is expected to decrease at a compound annual growth rate (CAGR) of -1.2%, reaching $200 million by 2032.

This report covers the global market for OPCAB devices, including stabilizer devices and positioner devices used during beating-heart coronary artery bypass procedures.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032 and historical data back to 2022.

Although the market is expected to decline, specialized device use and higher pricing in complex cases are expected to partially offset falling procedure volumes. Clinical benefits, reduced costs and selected patient suitability continue to support demand, while procedural difficulty and surgeon preference for ONCAB limit broader adoption.

Market Overview

The global OPCAB device market includes devices used during coronary artery bypass grafting procedures performed without a cardiopulmonary bypass pump.

OPCAB procedures are performed while the heart is still beating. Because the surgical field is moving, specialized stabilizers and positioners are required to help surgeons access target vessels and perform precise anastomoses.

The market is segmented into stabilizer devices and positioner devices. Stabilizers help reduce movement at the surgical site, while positioners assist in manipulating and exposing the heart during the procedure.

Overall procedure volumes are expected to remain under pressure as many cardiac surgeons continue to prefer on-pump coronary artery bypass (ONCAB) procedures. However, OPCAB remains clinically relevant in selected patient populations and complex cases where avoiding cardiopulmonary bypass may offer important benefits.

Market Drivers

Clinical Benefits of OPCAB

Patients who undergo OPCAB procedures may experience reduced rates of bleeding, neurocognitive effects, kidney complications and shorter hospital stays.

These benefits are primarily linked to the fact that a cardiopulmonary bypass pump is not used. Avoiding extracorporeal circulation can reduce some of the risks associated with exposing blood to artificial surfaces during ONCAB procedures.

These clinical advantages help slow the shift away from OPCAB and support continued device use in patients who may benefit from a beating-heart approach.

Although the total market is expected to decline, these benefits preserve a base level of demand for stabilizers and positioners in selected cardiac surgery programs.

Reduced Cost

OPCAB procedures can be less expensive than ONCAB procedures because the costly devices used during cardiopulmonary bypass are not required.

Patients may also recover more quickly after OPCAB procedures, which can reduce hospital costs associated with longer stays or additional post-operative management.

Hospitals that are focused on cost control may continue to favor OPCAB in appropriate cases, especially when clinical outcomes are comparable and patient anatomy supports the technique.

This cost advantage supports ongoing use of OPCAB devices, even as overall procedure growth remains constrained.

Specialized Device Use in Complex Cases

Despite declining procedure volumes, pricing dynamics are expected to partially offset market pressure.

In certain patient risk classes, OPCAB procedures may remain comparable to less invasive alternatives based on anatomical suitability and long-term outcomes. As a result, physicians may continue to select OPCAB for specific cases.

Specialized stabilizers and positioners are especially important in complex procedures, where precise exposure and stabilization are required.

The use of higher-priced devices in these cases is expected to support market value, even as overall procedure numbers decline.

Market Limiters

Inherent Procedural Difficulties

An OPCAB procedure is significantly more difficult to perform than an ONCAB procedure.

During OPCAB, the patient's heart is beating while the surgeon performs delicate anastomosis on a target vessel, which can be as narrow as 1 mm in internal diameter. This movement creates major technical challenges.

Surgeons are also often required to place a partially occluding clamp on the aorta to allow hand suturing of the proximal end of the graft anastomosis. As a result, even OPCAB patients may still face some adverse effects associated with aortic clamping.

Although anastomosis assist devices can help address this problem, their penetration rate within OPCAB procedures remains relatively low.

Surgeon Preference for ONCAB

Many physicians continue to prefer ONCAB when performing CABG procedures.

Surgeons may be reluctant to transition to OPCAB because it requires additional training and demands more technically challenging surgical techniques. This is particularly relevant among surgeons who have used ONCAB for most of their careers.

ONCAB provides a motionless and bloodless surgical field, which many surgeons view as more predictable for graft placement and suturing.

This preference for ONCAB continues to limit OPCAB adoption and is expected to impede stronger growth over the forecast period.

Declining and Moderating Procedure Demand

OPCAB device demand is closely tied to procedure volume.

As cardiac surgery patterns evolve and alternative treatment options continue to develop, overall demand for OPCAB procedures remains under pressure. The market is therefore constrained by both procedure decline and limited conversion from ONCAB.

Even where OPCAB has clinical advantages, adoption depends heavily on surgeon training, confidence and institutional practice patterns.

As a result, market value is expected to decline modestly despite the use of specialized devices and higher pricing in selected cases.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold and average selling prices.
  • Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032 and historical data back to 2022.
  • Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, device utilization assumptions and forecast trends.
  • Device scope: The report covers off-pump coronary artery bypass devices segmented into stabilizer devices and positioner devices.

Markets Covered and Segmentation

Off-Pump Coronary Artery Bypass Device Market

  • Device type: Stabilizer devices and positioners.

Stabilizer devices are used to reduce movement at the coronary target site during beating-heart CABG. These devices are essential to OPCAB procedures because they help create a more stable field while the heart continues to beat.

Positioner devices are used to lift, rotate or expose the heart so surgeons can access target vessels. These products support procedural visibility and improve access during complex grafting procedures.

Together, stabilizers and positioners allow surgeons to perform CABG without placing the patient on cardiopulmonary bypass. This makes them core device categories in the OPCAB market.

Because OPCAB procedures are technically demanding, product performance, ease of use, reliability and surgeon familiarity are important competitive factors.

The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold and average selling prices.

Competitive Analysis

Medtronic was the leading competitor in the global OPCAB market.

For stabilizers, Medtronic offers its Octopus(TM) Evolution, Octopus(TM) 4 and Octopus(TM) 4.3 tissue stabilizers. These products are used to stabilize the surgical field during beating-heart procedures.

The company's heart positioner portfolio includes Starfish(TM) Evo, Starfish(TM) 2, Urchin(TM) and Urchin(TM) 2. These devices complete Medtronic's OPCAB product offering across stabilization and positioning.

Since Medtronic has left the ventricular assist device market, it is expected that the company will expand its presence in the OPCAB segment. Its established cardiac surgery portfolio and broad global presence support its leadership in this market.

Getinge was the second-leading competitor in the global OPCAB market.

The company offers beating-heart stabilizers and positioners as part of its broader cardiac surgery product portfolio. Getinge participates across multiple segments and has shifted investments toward other areas.

Because the OPCAB market is declining, Getinge is expected to lose some market share in the coming years. However, its existing product base and established hospital relationships support continued participation.

Terumo captured the third-leading position in the total OPCAB market.

The company's Universal Stabilizer Arm(TM) introduced the concept of an articulating arm attached to a sternal retractor for cardiac surgery applications.

With a unique and innovative product portfolio, Terumo is likely to gain greater presence in the OPCAB market over the forecast period, particularly as customers seek reliable stabilization solutions for selected beating-heart procedures.

Technology and Practice Trends

Beating-Heart Surgery

OPCAB procedures are designed to avoid the use of cardiopulmonary bypass.

This approach remains important for selected patients who may benefit from avoiding extracorporeal circulation.

Stabilization Technology

Stabilizer devices are central to OPCAB procedure success.

Improved stabilization helps surgeons perform more precise grafting on a moving heart.

Heart Positioning Systems

Positioners support access to coronary vessels during beating-heart surgery.

These devices help improve exposure and allow surgeons to work across different target areas.

Cost-Focused Cardiac Surgery

OPCAB can reduce certain procedural costs by avoiding cardiopulmonary bypass equipment.

This supports continued interest among hospitals seeking lower-cost surgical approaches in appropriate patients.

Selective Patient Use

OPCAB is increasingly tied to selected patient profiles rather than broad CABG adoption.

Anatomical suitability, surgeon preference and patient risk factors influence whether OPCAB is chosen.

Pricing Support from Specialized Devices

Although procedure volumes are expected to decline, higher-priced specialized devices can support market value.

Complex OPCAB procedures may require advanced stabilizers and positioners, helping offset some volume pressure.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • How large is the global OPCAB device market today, and how much is it expected to change through 2032?
  • How are stabilizer devices and positioner devices performing across the forecast period?
  • Why is the overall OPCAB device market expected to decline?
  • How are higher device prices and specialized product use offsetting procedure volume pressure?
  • Which patient and procedure types continue to support OPCAB use?
  • How do OPCAB procedures compare with ONCAB in terms of clinical benefits and cost?
  • Why do procedural difficulty and training requirements limit adoption?
  • How does surgeon preference for ONCAB affect the outlook for OPCAB devices?
  • Which companies lead the global OPCAB device market?
  • How are Medtronic, Getinge and Terumo positioned across stabilizers, positioners and beating-heart surgery platforms?

The Global Off-Pump Coronary Artery Bypass Device Market Report from iData Research answers these questions with procedure-based models, ASP data, company share insights and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand OPCAB procedure trends and support commercial planning in the global OPCAB device market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Off-Pump Coronary Artery Bypass Device Market

  • 14.1 Executive Summary
    • 14.1.1 Global Off-Pump Coronary Artery Bypass Device Market Overview
    • 14.1.2 Competitive Analysis
    • 14.1.3 Procedures Included
    • 14.1.4 Markets Included
    • 14.1.5 Regions Included
  • 14.2 Introduction
  • 14.3 Procedure Numbers
    • 14.3.1 Total Coronary Artery Bypass Grafting Procedures
    • 14.3.2 Off-Pump Coronary Artery Bypass CABG Procedures
  • 14.4 Market Overview
    • 14.4.1 By Segment
    • 14.4.2 By Region
  • 14.5 Market Analysis And Forecast
    • 14.5.1 Total Off-Pump Coronary Artery Bypass Device Market
    • 14.5.2 Stabilizer Device Market
    • 14.5.3 Positioner Market
  • 14.6 Drivers And Limiters
    • 14.6.1 Market Drivers
    • 14.6.2 Market Limiters
  • 14.7 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

  • Chart 14-1: Off-Pump Coronary Artery Bypass Device Market, Global, 2025 & 2032
  • Chart 14-2: Off-Pump Coronary Artery Bypass Device Procedures, Global, 2025
  • Chart 14-3: Coronary Artery Bypass Grafting Procedures by Segment, Global, 2022 - 2032
  • Chart 14-4: Off-Pump Coronary Artery Bypass Device Market by Segment, Global, 2022 - 2032
  • Chart 14-5: Off-Pump Coronary Artery Bypass Device Market by Region, Global, 2022 - 2032
  • Chart 14-6: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, Global, 2025

LIST OF FIGURES

  • Figure 14-1: Off-Pump Coronary Artery Bypass Device Procedures Covered
  • Figure 14-2: Off-Pump Coronary Artery Bypass Device Markets Covered
  • Figure 14-3: Off-Pump Coronary Artery Bypass Device Regions Covered, Global (1 of 2)
  • Figure 14-4: Off-Pump Coronary Artery Bypass Device Regions Covered, Global (2 of 2)
  • Figure 14-5: Coronary Artery Bypass Grafting Procedures by Support Type, Global, 2022 - 2032
  • Figure 14-6: Coronary Artery Bypass Grafting Procedures by Region, Global, 2022 - 2032
  • Figure 14-7: Coronary Artery Bypass Grafting Procedures by Country, North America, 2022 - 2032
  • Figure 14-8: Coronary Artery Bypass Grafting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 14-9: Coronary Artery Bypass Grafting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 14-10: Coronary Artery Bypass Grafting Procedures by Country, Western Europe, 2022 - 2032
  • Figure 14-11: Coronary Artery Bypass Grafting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 14-12: Coronary Artery Bypass Grafting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 14-13: Coronary Artery Bypass Grafting Procedures by Country, Middle East, 2022 - 2032
  • Figure 14-14: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 14-15: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 14-16: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 14-17: Coronary Artery Bypass Grafting Procedures by Country, Africa, 2022 - 2032
  • Figure 14-18: Off-Pump Coronary Artery Bypass CABG Procedures by Region, Global, 2022 - 2032
  • Figure 14-19: Off-Pump Coronary Artery Bypass CABG Procedures by Country, North America, 2022 - 2032
  • Figure 14-20: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 14-21: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 14-22: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Western Europe, 2022 - 2032
  • Figure 14-23: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 14-24: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 14-25: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Middle East, 2022 - 2032
  • Figure 14-26: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 14-27: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 14-28: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 14-29: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Africa, 2022 - 2032
  • Figure 14-30: Off-Pump Coronary Artery Bypass Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 14-31: Off-Pump Coronary Artery Bypass Device Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 14-32: Off-Pump Coronary Artery Bypass Device Market, Global, 2022 - 2032
  • Figure 14-33: Units Sold by Region, Off-Pump Coronary Artery Bypass Device Market, Global, 2022 - 2032
  • Figure 14-34: Average Selling Price by Region, Off-Pump Coronary Artery Bypass Device Market, Global, 2022 - 2032 (US$)
  • Figure 14-35: Market Value by Region, Off-Pump Coronary Artery Bypass Device Market, Global, 2022 - 2032 (US$M)
  • Figure 14-36: Stabilizer Device Market, Global, 2022 - 2032
  • Figure 14-37: Units Sold by Region, Stabilizer Device Market, Global, 2022 - 2032
  • Figure 14-38: Average Selling Price by Region, Stabilizer Device Market, Global, 2022 - 2032 (US$)
  • Figure 14-39: Market Value by Region, Stabilizer Device Market, Global, 2022 - 2032 (US$M)
  • Figure 14-40: Positioner Market, Global, 2022 - 2032
  • Figure 14-41: Units Sold by Region, Positioner Market, Global, 2022 - 2032
  • Figure 14-42: Average Selling Price by Region, Positioner Market, Global, 2022 - 2032 (US$)
  • Figure 14-43: Market Value by Region, Positioner Market, Global, 2022 - 2032 (US$M)
  • Figure 14-44: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, Global, 2025